[Efficacy and safety of rituximab-contained regimen for refractory and relapsing thrombotic thrombocytopenic purpura: a retrospective study of 10 cases]
- PMID: 30369208
- PMCID: PMC7348278
- DOI: 10.3760/cma.j.issn.0253-2727.2018.10.013
[Efficacy and safety of rituximab-contained regimen for refractory and relapsing thrombotic thrombocytopenic purpura: a retrospective study of 10 cases]
Similar articles
-
A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.Br J Haematol. 2015 Jul;170(2):208-17. doi: 10.1111/bjh.13408. Epub 2015 Apr 8. Br J Haematol. 2015. PMID: 25855259 Clinical Trial.
-
Successful treatment of relapsing autoimmune thrombotic thrombocytopenic purpura with rituximab.Pediatr Int. 2014 Dec;56(6):914-918. doi: 10.1111/ped.12344. Pediatr Int. 2014. PMID: 25521977
-
[Efficacy and safety of rituximab therapy for refractory/relapsing thrombotic thrombocytopenic purpura].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Feb;35(1):116-20. doi: 10.3881/j.issn.1000-503X.2013.01.022. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013. PMID: 23469801 Chinese.
-
Immunotherapy for thrombotic thrombocytopenic purpura.Curr Opin Hematol. 2005 Sep;12(5):359-63. doi: 10.1097/01.moh.0000170534.33517.99. Curr Opin Hematol. 2005. PMID: 16093780 Review.
-
Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.Int J Hematol. 2005 Jun;81(5):433-6. doi: 10.1532/ijh97.04187. Int J Hematol. 2005. PMID: 16158827 Review.